Answers are grounded in this paper and cite their sources.
Background Research on the complement–microglia–synapse axis spans development and brain disorders, but the extent and consistency of changing disease-related attention require quantitative characterization. Methods We conducted a systematic bibliometric review of English-language publications dated 2000–2025, searching Web of Science Core Collection (WoSCC) and PubMed on 10 October 2026. Two reviewers independently screened records. Following metadata harmonization, separate database analyses examined collaboration, citation structure, keywords, and temporal patterns. Analyses included publication-year-specific citation comparisons and disease-mention counts and proportions. Cross-database comparisons used publication matching and a harmonized year window. Results Screening retained 1,334 WoSCC and 1,239 PubMed publications, including 1,110 shared publications. Developmental pruning and Alzheimer’s disease constituted central intellectual foundations. In WoSCC, Alzheimer’s disease mentions increased in absolute number while their trailing three-year pooled proportion declined from approximately 60–70% in the early 2000s to approximately one-quarter recently. Schizophrenia, depression, stroke, epilepsy, and autism mentions were more numerous in 2020–2024 than in earlier five-year periods, although relative trajectories differed. Across 132 shared author keywords, frequency rankings correlated strongly (Spearman’s ρ = 0.853). “Synaptic pruning” and “depression” had matching median years across databases, at 2022 and 2023, respectively. WoSCC-only publications had higher proportions of retinal-disorder and stroke mentions, whereas PubMed-only publications had a higher proportion of depression mentions. Conclusion Research attention diversified around an established knowledge base, with heterogeneous disease-related trajectories. The overlapping databases showed concordant core patterns and complementary coverage. These findings characterize scholarly attention and connectivity without establishing shared disease mechanisms or clinical efficacy. Systematic review registration https://osf.io/mbvdh/ , Project identifier: mbvdh .
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: